Zevra Therapeutics
Denmark - FrederiksbergBiotechnology
Focus: Zevra Therapeutics is a publicly traded biotech company focused on rare diseases through modification of existing drugs. The company operates from Denmark with a lean, specialized commercial footprint.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Open Jobs
11+3 this month
Stable — net +3 jobs in 30d
5 added, 2 removed. Backfill posture.
Should You Work at Zevra Therapeutics?
AI assessmentZevra offers rare-disease focus and commercial stability for specialists seeking specialty pharma experience, but limited growth scale for generalists seeking rapid advancement.
Why Work Here
- Peak revenue from APADAZ (benzhydrocodone/acetaminophen, LOE 2031) provides stable cash flow to fund rare disease pipeline
- Heavy hiring in Medical Affairs (6 of 12 open roles) signals commercial buildout and career velocity in specialty pharma commercialization
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
1 in 5yr
APADAZ
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Peak4.5yr
Sole approved product generating revenue; extended LOE through 2031 provides multi-year commercial runway.
Help build intelligence for Zevra Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.